Endra Life Sciences Announces The Issuance Of Three New Patents, Including One In The US And Two In China. Endra's Intellectual Property Portfolio Now Includes 70 Issued Patents Worldwide For The Novel Taeus System
Portfolio Pulse from Benzinga Newsdesk
Endra Life Sciences has announced the issuance of three new patents, one in the US and two in China. This expands Endra's intellectual property portfolio to 70 issued patents worldwide for the novel Taeus system.
November 08, 2023 | 1:08 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Endra Life Sciences' stock may see positive movement due to the issuance of three new patents, expanding its intellectual property portfolio.
The issuance of new patents strengthens Endra Life Sciences' intellectual property portfolio, which could increase investor confidence in the company's innovative capabilities and future growth potential. This could lead to a positive impact on the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100